This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 1999 Jun;60(6):410.

doi: 10.4088/jcp.v60n0611d.

SSRI-induced parkinsonism may be an early sign of future Parkinson's disease

A S Gönül, M Aksu

PMID: 10401924
DOI: 10.4088/jcp.v60n0611d

Case Reports

SSRI-induced parkinsonism may be an early sign of future Parkinson's disease

A S Gönül et al. J Clin Psychiatry. 1999 Jun.

. 1999 Jun;60(6):410.

doi: 10.4088/jcp.v60n0611d.

Authors

A S Gönül, M Aksu

PMID: 10401924
DOI: 10.4088/jcp.v60n0611d

No abstract available

PubMed Disclaimer

Similar articles

Movement disorders associated with the serotonin selective reuptake inhibitors.
Leo RJ. Leo RJ. J Clin Psychiatry. 1996 Oct;57(10):449-54. doi: 10.4088/jcp.v57n1002. J Clin Psychiatry. 1996. PMID: 8909330 Review.
Fluvoxamine and mandibular dystonia.
Chong SA. Chong SA. Can J Psychiatry. 1995 Sep;40(7):430-1. doi: 10.1177/070674379504000723. Can J Psychiatry. 1995. PMID: 8548729 No abstract available.
Do serotonin reuptake inhibitor antidepressants worsen Parkinson's disease? A retrospective case series.
Richard IH, Maughn A, Kurlan R. Richard IH, et al. Mov Disord. 1999 Jan;14(1):155-7. doi: 10.1002/1531-8257(199901)14:1<155::aid-mds1026>3.0.co;2-z. Mov Disord. 1999. PMID: 9918360 No abstract available.
Toxicity with selective serotonin reuptake inhibitors.
Solomons K, Gooch S, Wong A. Solomons K, et al. Am J Psychiatry. 2005 Jun;162(6):1225. doi: 10.1176/appi.ajp.162.6.1225. Am J Psychiatry. 2005. PMID: 15930079 No abstract available.
Fluvoxamine. A review of its safety profile in world-wide studies.
Wagner W, Zaborny BA, Gray TE. Wagner W, et al. Int Clin Psychopharmacol. 1994 Winter;9(4):223-7. doi: 10.1097/00004850-199400940-00001. Int Clin Psychopharmacol. 1994. PMID: 7868844 Review.

See all similar articles

Cited by

Depression and Parkinson's disease: a Chicken-Egg story.
Chakraborty A, Diwan A. Chakraborty A, et al. AIMS Neurosci. 2022 Nov 23;9(4):479-490. doi: 10.3934/Neuroscience.2022027. eCollection 2022. AIMS Neurosci. 2022. PMID: 36660077 Free PMC article. Review.
Neuroprotection or Neurotoxicity of Illicit Drugs on Parkinson's Disease.
Ferreira C, Almeida C, Tenreiro S, Quintas A. Ferreira C, et al. Life (Basel). 2020 Jun 11;10(6):86. doi: 10.3390/life10060086. Life (Basel). 2020. PMID: 32545328 Free PMC article. Review.
Parkinsonism secondary to duloxetine use: a case report.
Bayrak A, Cetin B, Meteris H, Kesebir S. Bayrak A, et al. North Clin Istanb. 2015 Dec 25;2(3):243-246. doi: 10.14744/nci.2015.63634. eCollection 2015. North Clin Istanb. 2015. PMID: 28058376 Free PMC article.
A Case of SSRI Induced Irreversible Parkinsonism.
Dixit S, Khan SA, Azad S. Dixit S, et al. J Clin Diagn Res. 2015 Feb;9(2):VD01-VD02. doi: 10.7860/JCDR/2015/11394.5583. Epub 2015 Feb 1. J Clin Diagn Res. 2015. PMID: 25859504 Free PMC article.
Monoamine reuptake inhibitors in Parkinson's disease.
Huot P, Fox SH, Brotchie JM. Huot P, et al. Parkinsons Dis. 2015;2015:609428. doi: 10.1155/2015/609428. Epub 2015 Feb 25. Parkinsons Dis. 2015. PMID: 25810948 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information